report banner

News in English

PostNews: Press Release

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 14 March 2024

On Thursday, March 14, 2024, Phase Holographic Imaging PHI AB (publ), held an extraordinary general meeting. The following resolutions were passed at the meeting.
Learn more …
PostNews: Press Release
blue-cells_white-bg_banner

Shaping the future of Regenerative Medicine – PHI’s vision for QPI in Cell Therapy Manufacturing

PHI presents a comprehensive opinion piece detailing the versatility and potential the Company sees for Quantitative Phase Imaging (QPI) technology in Regenerative Medicine. PHI outlines how QPI will offer enhanced cell quality control in the cell manufacturing process, thereby addressing a central puzzle piece for making cell-based therapies safe, affordable, and accessible for all.
Learn more …
PostNews: Press Release
Altium_logo

New Distributor Partner Manager at Altium set to enhance global sales for PHI

PHI is conveying the news that its global distributor, Altium ., has appointed a PHI-dedicated distributor partner manager. This strategic step is set to significantly enhance the reach and sales performance of PHI’s HoloMonitor technology on a global scale.
Learn more …
PostNews: Press Release

Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 14 March 2024

Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an extraordinary general meeting on 14 March 2024 at 10.00 am at the Company’s premises, Skiffervägen 48 in Lund.
Learn more …
PostNews
Biostock PHI one year CEO anniversary

BioStock: PHI “We aim to revolutionize the regenerative medicine market“

BioStock talked to PHI’s CEO, Patrik Eschricht, about the eventful past year and his vision for the company’s future within regenerative medicine.
Learn more …
PostNews: Press Release
PHI-at-RedEye-Regenerative-Medicine-and-Cell-Therapy-event-2024

PHI presents at the Redeye Regenerative Medicine & Cell Therapy 2024

PHI is delighted to participate in the Redeye Regenerative Medicine and Cell Therapy event on Wednesday, February 14, 2024.
Learn more …
12332